SARS-CoV-2-IN-13 (compound 5) is a potent inhibitor of SARS-CoV-2 with an IC 50 of 0.057 μM. SARS-CoV-2-IN-13 is a niclosamide analogue. SARS-CoV-2-IN-13 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally.Form:Solid.
Specifications and Purity: ≥98%
Molecular Formula: C13H8Cl2N2O4
Molecular Weight: 327.12
- UPC:
- 42201501
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- S647437-100mg
- CAS:
- 56961-10-5
- Product Size:
- 100mg
akash.verma@cenmed.com
(732) 447-1115





